Trial Profile
Comparison of Two Different Treatment Strategies in Patients With Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jan 2022
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary) ; Escitalopram
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms HMGD
- Sponsors Eli Lilly and Company
- 04 Jul 2012 Planned number of patients changed from 580 to 1160 as reported by EudraCT.
- 05 Dec 2011 Results presented at the 11th International Forum on Mood and Anxiety Disorders.
- 12 Mar 2010 Actual number of patients (522) added as reported by ClinicalTrials.gov.